Roskamm H, Schnellbacher K, Samek L, Betz P
Eur Heart J. 1983 Jan;4 Suppl A:127-30. doi: 10.1093/eurheartj/4.suppl_a.127.
Quantification of heart failure is possible with hemodynamic parameters such as cardiac output and filling pressure at rest and during exercise. These parameters can easily but invasively be achieved by floating catheter measurements. In our experience, the risk of this method is low but existent. In greater than 20 000 patients with chronic diseases no death occurred in connection with the procedure; 26 patients developed ventricular fibrillation or ventricular tachycardias which made defibrillation necessary in 10 of these patients. In three patients asystolia demanded resuscitation. Hemoptysis did not occur. In the acute stage of a disease, e.g. in the acute myocardial infarction, the risk may be higher, especially if the catheter remains in the circulation for longer periods. The possibilities and limitations of the method will be discussed for the following patient groups: (1) Patients with acute myocardial infarction, (2) Postinfarction patients, (3) Patients with cardiomyopathies, (4) Patients with valvular heart disease.
通过诸如静息和运动时的心输出量及充盈压等血流动力学参数来量化心力衰竭是可行的。这些参数可通过漂浮导管测量轻松但具有侵入性地获得。根据我们的经验,这种方法的风险较低但确实存在。在超过20000例慢性病患者中,没有因该操作导致死亡;26例患者发生室颤或室性心动过速,其中10例患者需要进行除颤。3例患者出现心搏停止需要复苏。未发生咯血。在疾病的急性期,如急性心肌梗死,风险可能更高,尤其是当导管在循环系统中留置较长时间时。将针对以下患者群体讨论该方法的可能性和局限性:(1)急性心肌梗死患者,(2)心肌梗死后患者,(3)心肌病患者,(4)心脏瓣膜病患者。